Tiande Chemical Holdings Limited (HK:0609)
:0609
Top Page
Tiande Chemical Holdings Limited
(0609)
Select Model
Select Model
Rating:61Neutral
Price Target:
HK$1.50
▲(5.63% Upside)
Action:ReiteratedDate:12/30/25
The score is driven primarily by weakening profitability and margin compression, partially offset by a conservative balance sheet and continued positive free cash flow. Technical indicators are broadly neutral, while valuation is fair with a moderate dividend yield but a mid-range P/E.
Positive Factors
Conservative balance sheet / low leverage
Very low leverage (D/E ~0.09 in 2024, effectively zero in 2023) and a sizable equity base (~2.42B vs total assets ~3.08B) give the company durable financial flexibility. This conservatism supports capital allocation, cushions cyclicality, and preserves room for investment or shareholder returns over the medium term.
Negative Factors
Sharp margin compression
Rapid erosion of gross and net margins signals persistent cost or pricing pressure and reduced pricing power. Such structural margin degradation directly weakens long-term profitability, lowers reinvestment capacity, and makes earnings more sensitive to volume swings and input-cost inflation over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet / low leverage
Very low leverage (D/E ~0.09 in 2024, effectively zero in 2023) and a sizable equity base (~2.42B vs total assets ~3.08B) give the company durable financial flexibility. This conservatism supports capital allocation, cushions cyclicality, and preserves room for investment or shareholder returns over the medium term.
Read all positive factors
Tiande Chemical Holdings Limited (0609) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$1.19B
Dividend Yield3.52%
Average Volume (3M)225.60K
Price to Earnings (P/E)18.5
Beta (1Y)0.26
Revenue Growth-5.29%
EPS Growth-32.47%
CountryHK
Employees1,358
SectorBasic Materials
Sector Strength58
IndustryChemicals
Share Statistics
EPS (TTM)0.03
Shares Outstanding878,418,000
10 Day Avg. Volume119,200
30 Day Avg. Volume225,600
Financial Highlights & Ratios
PEG Ratio-0.21
Price to Book (P/B)0.39
Price to Sales (P/S)0.50
P/FCF Ratio4.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Tiande Chemical Holdings Limited Business Overview & Revenue Model
Company Description
Tiande Chemical Holdings Limited, an investment holding company, engages in the research, development, manufacture, sale, and distribution of fine chemical products in the People's Republic of China, India, the United States, Taiwan, the United Ki...
How the Company Makes Money
Tiande Chemical Holdings Limited generates revenue through the production and sale of its chemical products. The company's key revenue streams include the sale of cyanoacetic acid and its derivatives, which are used in the synthesis of pharmaceuti...
Tiande Chemical Holdings Limited Financial Statement Overview
Summary
Income Statement
44
Neutral
Balance Sheet
74
Positive
Cash Flow
72
Positive
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.82B | 1.87B | 2.08B | 3.52B | 2.58B | 1.36B |
| Gross Profit | 200.07M | 227.48M | 438.84M | 1.48B | 777.87M | 181.13M |
| EBITDA | 160.26M | 154.21M | 436.44M | 1.40B | 678.07M | 144.80M |
| Net Income | 59.68M | 66.88M | 211.07M | 870.92M | 379.65M | 94.82M |
Balance Sheet | ||||||
| Total Assets | 3.18B | 3.08B | 2.92B | 2.96B | 2.32B | 1.92B |
| Cash, Cash Equivalents and Short-Term Investments | 848.92M | 851.55M | 615.06M | 492.13M | 226.35M | 125.31M |
| Total Debt | 354.19M | 220.13M | 0.00 | 45.72M | 154.76M | 215.51M |
| Total Liabilities | 678.38M | 569.51M | 364.24M | 456.06M | 561.92M | 536.01M |
| Stockholders Equity | 2.43B | 2.42B | 2.44B | 2.41B | 1.75B | 1.39B |
Cash Flow | ||||||
| Free Cash Flow | 113.33M | 195.67M | 330.76M | 592.74M | 60.86M | -45.32M |
| Operating Cash Flow | 293.93M | 395.43M | 649.23M | 854.84M | 274.33M | 170.53M |
| Investing Cash Flow | 199.29M | -219.65M | -543.42M | -469.45M | -84.39M | -180.60M |
| Financing Cash Flow | 3.37M | 6.65M | -232.55M | -337.13M | -88.77M | -29.44M |
Tiande Chemical Holdings Limited Technical Analysis
Negative
1.42
Price Trends
1.52
Negative
1.48
Negative
1.39
Negative
Market Momentum
-0.05
Positive
38.39
Neutral
35.92
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0609, the sentiment is Negative. The current price of 1.42 is above the 20-day moving average (MA) of 1.41, below the 50-day MA of 1.52, and above the 200-day MA of 1.39, indicating a bearish trend. The MACD of -0.05 indicates Positive momentum. The RSI at 38.39 is Neutral, neither overbought nor oversold. The STOCH value of 35.92 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0609.
Tiande Chemical Holdings Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | HK$4.09B | 7.74 | 6.29% | 6.70% | -3.73% | 6.09% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | HK$1.19B | 18.52 | 2.55% | 3.52% | -5.29% | -32.47% | |
59 Neutral | HK$1.24B | 7.69 | 7.36% | 2.20% | -8.51% | -68.34% | |
52 Neutral | HK$6.02B | 8.07 | 7.70% | ― | 9.20% | 213.87% | |
43 Neutral | HK$372.49M | -0.19 | -179.93% | ― | -22.72% | -212.73% |
* Basic Materials Sector Average
HK:0609
Tiande Chemical Holdings Limited
1.35
0.40
42.11%
HK:0827
Ko Yo Chemical (Group) Limited
0.05
0.02
70.97%
HK:1702
Dongguang Chemical Ltd.
1.99
0.50
33.56%
HK:2198
China Sanjiang Fine Chemicals Co., Ltd.
5.13
3.67
251.37%
HK:0746
Lee & Man Chemical Co. Ltd.
4.96
1.64
49.40%
Tiande Chemical Holdings Limited Corporate Events
Tiande Chemical Announces 2026 Board Line-up and Committee Roles
Dec 31, 2025
Tiande Chemical Holdings Limited has announced the composition of its board of directors with effect from 1 January 2026, naming Liu Yang as chairman alongside executive directors Chen Xiaohua and Dou Aobo, non-executive director Wang Zijiang, and...
Tiande Chemical to Fully Consolidate Key Subsidiary with RMB88 Million Stake Purchase
Dec 29, 2025
Tiande Chemical Holdings Limited has agreed to acquire the remaining 49% equity interest in a non-wholly owned subsidiary from an existing substantial shareholder for RMB88 million, turning the target into an indirect wholly owned subsidiary. The ...
Tiande Chemical Tightens Audit Committee Charter to Bolster Governance
Dec 29, 2025
Tiande Chemical Holdings Limited has revised and approved updated terms of reference for its audit committee, effective 23 December 2025, formalising requirements that the committee comprise at least three members drawn from independent non-execut...
Tiande Chemical Tightens Governance With Updated Remuneration Committee Mandate
Dec 29, 2025
Tiande Chemical Holdings Limited has revised and approved updated terms of reference for its remuneration committee, effective 23 December 2025, setting out the committee’s composition, roles and operating procedures. The new terms formalize...
Tiande Chemical Strengthens Governance With New Nomination Committee Appointment
Dec 23, 2025
Tiande Chemical Holdings has appointed independent non-executive director Ms. Shan Honghong as a member of its nomination committee, effective 1 January 2026, expanding the committee to four members. The board stated that this move is intended to ...
Tiande Chemical Reshapes Board as Co‑Founder Steps Back and Deputy GM Becomes Executive Director
Dec 23, 2025
Tiande Chemical Holdings Limited has announced board changes effective 1 January 2026, with co‑founder and long‑serving executive director Wang Zijiang to be re‑designated as a non‑executive director so he can devote more t...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.